Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No effect of topical digoxin and furosemide gel for patients with external anogenital warts.
Rijsbergen M, Rijneveld R, Todd M, Pagan L, Feiss G, de Koning MNC, van Alewijk DCJG, Klaassen ES, Burggraaf J, Rissmann R, van Poelgeest MIE. Rijsbergen M, et al. Among authors: klaassen es. J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e45-e46. doi: 10.1111/jdv.15894. Epub 2019 Sep 11. J Eur Acad Dermatol Venereol. 2020. PMID: 31430405 No abstract available.
Renal Effects of Antisense-Mediated Inhibition of SGLT2.
van Meer L, Moerland M, van Dongen M, Goulouze B, de Kam M, Klaassen E, Cohen A, Burggraaf J. van Meer L, et al. J Pharmacol Exp Ther. 2016 Nov;359(2):280-289. doi: 10.1124/jpet.116.233809. Epub 2016 Sep 7. J Pharmacol Exp Ther. 2016. PMID: 27605629 Clinical Trial.
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.
Balak DM, van Doorn MB, Arbeit RD, Rijneveld R, Klaassen E, Sullivan T, Brevard J, Thio HB, Prens EP, Burggraaf J, Rissmann R. Balak DM, et al. Clin Immunol. 2017 Jan;174:63-72. doi: 10.1016/j.clim.2016.09.015. Epub 2016 Nov 20. Clin Immunol. 2017. PMID: 27876460 Clinical Trial.
An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.
Baakman AC, Alvarez-Jimenez R, Rissmann R, Klaassen ES, Stevens J, Goulooze SC, den Burger JCG, Swart EL, van Gerven JMA, Groeneveld GJ. Baakman AC, et al. Among authors: klaassen es. Br J Clin Pharmacol. 2017 Aug;83(8):1676-1687. doi: 10.1111/bcp.13268. Epub 2017 Apr 8. Br J Clin Pharmacol. 2017. PMID: 28217868 Free PMC article. Clinical Trial.
Topical ionic contra-viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts.
van der Kolk T, Dillingh MR, Rijneveld R, Klaassen ES, de Koning MNC, Kouwenhoven STP, Genders RE, Bouwes Bavinck JN, Feiss G, Rissmann R, Burggraaf J. van der Kolk T, et al. Among authors: klaassen es. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2088-2090. doi: 10.1111/jdv.14527. Epub 2017 Sep 6. J Eur Acad Dermatol Venereol. 2017. PMID: 28833595 Free PMC article.
Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.
van der Kolk T, Assil S, Rijneveld R, Klaassen ES, Feiss G, Florencia E, Prens EP, Burggraaf J, Moerland M, Rissmann R, van Doorn MBA. van der Kolk T, et al. Among authors: klaassen es. Clin Transl Sci. 2018 Nov;11(6):607-615. doi: 10.1111/cts.12563. Epub 2018 Jul 3. Clin Transl Sci. 2018. PMID: 29768709 Free PMC article. Clinical Trial.
A randomized controlled proof-of-concept trial of digoxin and furosemide in adults with cutaneous warts.
Rijsbergen M, Niemeyer-van der Kolk T, Hogendoorn G, Kouwenhoven S, Lemoine C, Klaassen ES, de Koning M, Beck S, Bouwes Bavinck JN, Feiss G, Burggraaf J, Rissmann R. Rijsbergen M, et al. Among authors: klaassen es. Br J Dermatol. 2019 May;180(5):1058-1068. doi: 10.1111/bjd.17583. Epub 2019 Mar 7. Br J Dermatol. 2019. PMID: 30580460 Free PMC article. Clinical Trial.
48 results